Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 228.3 | 156.7 | 125.4 | 111.8 | 42.6 |
| Revenue growth | 45.7% | 24.9% | 12.2% | 162.3% | |
| Cost of goods sold | 215.3 | 197.5 | 97.7 | 105.7 | 51.3 |
| Gross profit | 13.1 | -40.8 | 27.7 | 6.1 | -8.6 |
| Gross margin | 5.7% | -26.1% | 22.1% | 5.4% | -20.2% |
| General and administrative | 16.0 | 12.1 | 11.3 | 5.7 | 6.2 |
| EBIT | -3.0 | -52.9 | 16.4 | 11.8 | -2.4 |
| EBIT margin | -1.3% | -33.8% | 13.1% | 10.5% | -5.7% |
| Pre-tax income | -51.3 | -73.9 | 0.3 | 1.6 | -4.6 |
| Income taxes | -0.4 | -0.4 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.8% | 0.5% | 0.0% | 0.0% | 0.0% |
| Net income | -50.9 | -73.5 | 0.3 | 1.6 | -4.6 |
| Net margin | -22.3% | -46.9% | 0.3% | 1.5% | -10.7% |
| |
| Diluted EPS | ($0.17) | ($0.29) | $0.00 | $0.01 | ($0.02) |
| Shares outstanding (diluted) | 294.9 | 252.1 | 252.1 | 236.3 | 200.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|